Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. - Wikidata - wikimedia - TriplyDB

Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England.

Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England.

http://www.wikidata.org/entity/Q51114815

about

Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients Emergency action plans for people at risk of anaphylaxis (major allergy)Glucocorticoids for the treatment of anaphylaxis Emergency action plans for people at risk of anaphylaxis (major allergy)Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community Glucocorticoids for the treatment of anaphylaxis Trends in the epidemiology of asthma in England: a national study of 333,294 patients Trends in the epidemiology of smoking recorded in UK general practice Trends in the epidemiology and prescribing of medication for eczema in England Incidence and prevalence of multiple allergic disorders recorded in a national primary care database Causes and risk factors for anaphylaxis Anaphylaxis Imaging: Non-Invasive Measurement of Surface Body Temperature and Physical Activity in Small Animals Clinical evaluation of pediatric anaphylaxis and the necessity for multiple doses of epinephrine.Multifactorial Modulation of Food-Induced Anaphylaxis Perspectives on anaphylaxis epidemiology in the United States with new data and analyses.Higher latitude and lower solar radiation influence on anaphylaxis in Chilean children.Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland.World allergy organization guidelines for the assessment and management of anaphylaxis.Anaphylaxis treatment: current barriers to adrenaline auto-injector use.Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medici Anaphylaxis following atropine administration during general anesthesia: a case report.Anaphylaxis cases presenting to primary care paramedics in Quebec.Risk of anaphylaxis after vaccination in children and adults Characteristics of Anaphylaxis in 907 Chinese Patients Referred to a Tertiary Allergy Center: A Retrospective Study of 1,952 Episodes Anaphylaxis in the community: a questionnaire survey of members of the UK Anaphylaxis Campaign.Latitude, sunlight, vitamin D, and childhood food allergy/anaphylaxis.The epidemiology of anaphylaxis in Europe: a systematic review.Prescription rates of adrenaline auto-injectors for children in UK general practice: a retrospective cohort study.Multivalent paediatric allergy vaccines protect against allergic anaphylaxis in mice.Anaphylaxis: epidemiology, aetiology and relevance for the clinic.Patient perceptions of epinephrine auto-injectors: exploring barriers to use.Rate of recurrent anaphylaxis and associated risk factors among Olmsted County, Minnesota, residents: A population-based study.Epinephrine Autoinjector Prescribing Trends: An Outpatient Population-Based Study in Olmsted County, Minnesota.Design and validation of pictograms in a pediatric anaphylaxis action plan.Anaphylaxis in an emergency setting - elicitors, therapy and incidence of severe allergic reactions.Excess subcutaneous tissue may preclude intramuscular delivery when using adrenaline autoinjectors in patients with anaphylaxis.Recognition and treatment of anaphylaxis in the community.Anaphylaxis admissions to UK critical care units between 2005 and 2009.Recognition and treatment of anaphylaxis in hospital.

P2860

Q22305515-34AACD73-E2DF-4D0A-A0E0-704736DD0B5A Q24185841-4C15D04F-736A-4980-93EF-C5C9F4753B8F Q24200443-21EBA297-D3CE-45B2-BE42-41CDCE3E261B Q24200750-EA7F56FE-90A2-4632-B127-C6B2B191A135 Q24201463-03E8FDDB-19B1-4577-9157-00A0E622DB98 Q24235431-B43991CE-A05A-4A48-95F6-AE245DE81024 Q24236588-98B86061-1420-4C54-8525-B6C07B794345 Q24623019-C3BEB69C-D447-464C-86C0-2EE800081028 Q24642056-03F3ED84-F324-4C33-8163-7E7C85C67A6D Q24651254-FBF68787-6629-4DCE-8ED6-F69B69746493 Q24654735-902F863F-C7E7-44A6-A01B-9FD38BA81CCE Q27009246-474ABB7D-077C-4978-86F3-2FE2F414F403 Q27318703-06E09B9F-D524-4C5E-B792-91095260AFF8 Q33162761-A3C82E06-4E13-4B0F-ADF2-DBECEB929B56 Q33690086-A5C21E86-717E-45E8-BEB2-8A0A920E9861 Q33736062-5142379A-D23F-4CD9-AC7E-486A857684C3 Q33801084-BFF784AD-60A9-4BAE-A830-20DBC58AC66D Q33822081-BDC1B5C7-EEE1-4EC1-BE24-61AE1409B76F Q34319703-71A664D5-4CDC-4F8F-BD76-9F652D1D0609 Q34420331-4F0992F0-4128-4EA1-AC39-102E546D9011 Q35777144-61F75DE8-121B-4ED3-9802-8AF6C1764A2A Q36177207-5009D7A5-9EBB-48F8-9558-50263F2CD74F Q36410581-5B00F4AB-E6C9-4ED6-9A34-39E129AB7805 Q36665226-C7F7F8D5-DEA2-4EB9-B076-3AD3D5063284 Q36859374-C877EFDC-3DD7-4B4B-92CB-82D817B21B34 Q37514618-2D3A4AE9-A8EA-4D68-85A3-41A71D3B78EE Q37946741-18CDA7B2-E3D2-4700-BB6F-F5685829BFEA Q38151836-EFC531BD-BF68-4C7B-9748-5A5C01FFF603 Q38910501-0C753073-8BBF-4565-BE9C-BEB02F13A9A4 Q39305632-A4A05DC0-0971-4D22-9C8C-E8CBDCD43A91 Q39340740-A8B37F34-6AD8-4234-BCB3-2DCF807446C1 Q40051901-16367C4E-68E9-43D7-B171-96B2DA71E8F4 Q40423488-19152250-7DF9-4706-ABBC-9ECE6103777D Q40709252-0A79E6C8-C73D-4877-86C2-F9C14C0AEE42 Q41372972-DAE323F8-F95B-4300-A22A-EE93678E371E Q41973648-959A811E-AB56-45AD-8290-0EE1290FA10B Q42177436-E40E1EB4-ED64-4572-B3E5-5ABFFDB11AE7 Q44320134-79376CF5-160F-4437-AEBE-7CAB725C5B41 Q45190779-D2012DEB-A6AE-4862-81AC-79FCF911E1CC Q45572168-D399B924-A277-4E5D-8FD7-EE40E3C55A1F

P2860

Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England.

http://www.wikidata.org/entity/Q51114815

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Trends in national incidence, ...... ng for anaphylaxis in England.

@en

Trends in national incidence, ...... ng for anaphylaxis in England.

@nl

type

label

Trends in national incidence, ...... ng for anaphylaxis in England.

@en

Trends in national incidence, ...... ng for anaphylaxis in England.

@nl

prefLabel

Trends in national incidence, ...... ng for anaphylaxis in England.

@en

Trends in national incidence, ...... ng for anaphylaxis in England.

@nl

P1433

Q51114815-566D4BFF-711A-4F13-93CD-12342FC82FBE

P1476

Q51114815-0AF75DD5-4A92-423B-8D52-8868F5C0B1A0

P2093

Q51114815-2BAAF379-C225-400F-837C-214B2A322E33

Q51114815-BCAB29C6-566B-4775-B8A9-7CC52CA50BA5

P2860

Q51114815-1C617E1E-792B-459A-BE5E-4A954FA1A4E3

Q51114815-21A64CB3-5CC6-496B-A54A-2842FE418DF7

Q51114815-3E7458B9-9431-4FE5-BD19-480626F41D16

Q51114815-5B2D39C3-BD7C-4A6F-94E7-AA4AD317C25C

Q51114815-63EEF447-215C-411D-86CD-E46648DC0D98

Q51114815-710E95DE-0A4A-4D45-959E-C1FEA388DAF2

Q51114815-7F6B6204-78F9-4A79-86B0-725B8491BB22

Q51114815-A5A463C3-111D-4D09-9CA8-19CC4D9994EB

Q51114815-AF5B97A9-DB30-4528-A54A-98042334AA59

Q51114815-CBF8A18D-A348-471E-9EA7-819C96B9CF9C

P304

Q51114815-72C77574-EE92-49F1-B222-007C3FEBEB91

P31

Q51114815-C6B6DF30-A000-4C37-A693-3446E4A3ABD1

P356

Q51114815-A7222C06-F734-432B-91B7-4840E76FCFED

P407

Q51114815-07E60B4E-769C-4D6E-AA77-056C9A05A28C

P433

Q51114815-2C673CC0-ACF8-42E8-A539-3B40C2D520C1

P478

Q51114815-57C64A1F-DA43-4DFB-89FC-A5265D208341

P50

Q51114815-139009CB-B228-4354-8CB7-2309C851DAAC

Q51114815-88A94918-E133-416C-BC8D-A87163C18DCF

P577

Q51114815-4FF17E08-0E6E-418B-BAFC-EBA0E14CA61A

P5875

Q51114815-5777613F-4A37-438A-A37A-E20BC12DE673

P698

Q51114815-11737A45-A8EC-457A-9D8C-ACFD2A93AC35

P921

Q51114815-7B9294B8-C624-4FBF-A084-07DF7A61CFA2

P932

Q51114815-B000033E-8D4A-4557-8CAD-4993B10D4B89

P356

JRSM.2008.070306

P1433

Journal of the Royal Society of Medicine

P1476

Trends in national incidence, ...... ing for anaphylaxis in England

@en

P2093

John Newton

http://www.w3.org/2001/XMLSchema#string

Justin Fenty

http://www.w3.org/2001/XMLSchema#string

P2860

Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data.

Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data.

Exploiting the potential of routine data to better understand the disease burden posed by allergic disorders.

Burden of allergic disease in the UK: secondary analyses of national databases.

Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization.

Time trends in allergic disorders in the UK.

Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group.

Hospital admissions for acute anaphylaxis: time trend study.

The incidence, aetiology and management of anaphylaxis presenting to an accident and emergency department.

Anaphylaxis: risk factors for recurrence.

P304

139-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1258/JRSM.2008.070306

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Julia Hippisley-Cox

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5508814

http://www.w3.org/2001/XMLSchema#string

P698

18344471

http://www.w3.org/2001/XMLSchema#string

P921

P932

2270246

http://www.w3.org/2001/XMLSchema#string